Back
Tri Pointe Homes Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
68
TPH
Tri Pointe Homes
Last Price:
46.05
Seasonality Move:
8.49%
Sell
44
MIRM
Mirum Pharmaceuticals
Last Price:
39.35
Seasonality Move:
5.99%
Buy
68
Tri Pointe Homes (TPH)
is a Buy
Is Tri Pointe Homes a Buy, Sell or Hold?
- The current Tri Pointe Homes [TPH] share price is $46.01. The Score for TPH is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- TPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $39.34. The Score for MIRM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TPH Stock Price Chart
What is Tri Pointe Homes's stock price today?
-
The Tri Pointe Homes share price today is $46.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $39.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.
TPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 66.1 | Buy |
| Chaikin Money Flow: | 390571 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.1 - 44.88) | Buy |
| Bollinger Bands (100): | (37.61 - 43.79) | Buy |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 44.04 | Sell |
| Chaikin Money Flow: | 27576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.13 - 42.69) | Sell |
| Bollinger Bands (100): | (27.3 - 41.42) | Buy |
TPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.94 | Buy |
| 20-day SMA: | 43.84 | Buy |
| 50-day SMA: | 43.37 | Buy |
| 200-day SMA: | 37.83 | Buy |
| 8-day EMA: | 44.39 | Buy |
| 20-day EMA: | 43.68 | Buy |
| 50-day EMA: | 42.6 | Buy |
| 200-day EMA: | 38.02 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.48 | Sell |
| 20-day SMA: | 41.45 | Sell |
| 50-day SMA: | 40.72 | Sell |
| 200-day SMA: | 31.06 | Buy |
| 8-day EMA: | 40.12 | Sell |
| 20-day EMA: | 40.8 | Sell |
| 50-day EMA: | 39.41 | Sell |
| 200-day EMA: | 32.87 | Buy |
Tri Pointe Homes Earnings Growth & TPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.24 per share, an increase this year of $1.49 per share, and an increase next year of $0.21 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
Tri Pointe Homes Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||